United States
Print page content Print
Increase text size Decrease text size
Text Size


(lincomycin hydrochloride)

Proven effective in treating skin and upper respiratory infections


LINCOCIN (lincomycin hydrochloride) is indicated in the treatment of infections caused by Gram-positive organisms that are sensitive to its action, particularly streptococci and staphylococci.

LINCOCIN is indicated for the treatment of skin infections (pustular dermatitis, abscesses, infected wounds [including bite and fight wounds]), upper respiratory tract infections (tonsillitis, laryngitis), metritis, and secondary bacterial infections associated with the canine distemper-hepatitis complex.

LINCOCIN is indicated for the treatment of localized infections, such as abscesses, pneumonitis, and feline rhinotracheitis.

Each mL containing lincomycin hydrochloride equivalent to lincomycin, 50 mg; preserved with methylparaben 0.075%, propylparaben 0.025%, and sorbic acid 0.1%. Supplied in 20 mL bottles with graduated dropper.

Collapse All
    • Proven effective in treating the most common upper respiratory tract infections, septicemia, and infections of the skin and adjoining tissues.
    • Treats staphylococcal infections resistant to other antibiotics and sensitive to lincomycin.
    • Rapidly absorbed following oral administration.
    • No refrigeration needed.

Do not use LINCOCIN in animals with a history of hypersensitivity to clindamycin or lincomycin, in animals with known preexisting monilial infections or in unapproved species.

See full Prescribing Information, attached.